Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (201) 201
oncology (162) 162
female (155) 155
index medicus (152) 152
middle aged (152) 152
aged (131) 131
breast cancer (109) 109
adult (108) 108
cancer (102) 102
lymphatic metastasis (101) 101
prognosis (85) 85
surgery (82) 82
chemotherapy (81) 81
male (76) 76
care and treatment (69) 69
neoplasm staging (69) 69
breast neoplasms - pathology (67) 67
survival (66) 66
radiotherapy (59) 59
chemotherapy, adjuvant (58) 58
treatment outcome (54) 54
lymph nodes - pathology (53) 53
retrospective studies (53) 53
node positive (49) 49
node-positive (48) 48
breast neoplasms - drug therapy (47) 47
carcinoma (47) 47
disease-free survival (46) 46
aged, 80 and over (44) 44
analysis (44) 44
adjuvant chemotherapy (42) 42
breast neoplasms - mortality (42) 42
metastasis (41) 41
survival rate (38) 38
therapy (38) 38
follow-up studies (37) 37
hematology, oncology and palliative medicine (36) 36
survival analysis (35) 35
medicine & public health (34) 34
research (33) 33
node-positive head (32) 32
adjuvant treatment (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
dissection (30) 30
node-positive breast cancer (30) 30
women (30) 30
lymphatic system (28) 28
radiation-therapy (28) 28
risk (28) 28
squamous-cell carcinoma (28) 28
metastases (27) 27
health aspects (26) 26
patients (26) 26
prostate cancer (26) 26
radiation therapy (26) 26
biopsy (25) 25
cyclophosphamide (25) 25
lymph nodes (25) 25
patient outcomes (25) 25
radiotherapy, adjuvant (25) 25
adjuvant therapy (24) 24
lymph node excision (24) 24
radical prostatectomy (24) 24
cancer patients (23) 23
kaplan-meier estimate (23) 23
abridged index medicus (22) 22
breast neoplasms - surgery (22) 22
proportional hazards models (22) 22
radiology, nuclear medicine & medical imaging (21) 21
trial (21) 21
urology & nephrology (21) 21
risk factors (20) 20
adjuvant (19) 19
docetaxel (19) 19
tamoxifen (19) 19
combined modality therapy (18) 18
lymph node positive (18) 18
lymphatic metastasis - pathology (18) 18
management (18) 18
multivariate analysis (18) 18
neoplasm recurrence, local (18) 18
time factors (18) 18
antineoplastic agents - therapeutic use (17) 17
axilla (17) 17
carcinoma, squamous cell - pathology (17) 17
clinical trials (17) 17
neoadjuvant chemotherapy (17) 17
squamous cell carcinoma (17) 17
breast neoplasms - metabolism (16) 16
breast neoplasms - therapy (16) 16
cancer therapies (16) 16
head and neck cancer (16) 16
medical prognosis (16) 16
oncology, experimental (16) 16
predictive value of tests (16) 16
prospective studies (16) 16
radiation (16) 16
randomized-trial (16) 16
adjuvant radiotherapy (15) 15
carcinoma, squamous cell - surgery (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The 21-gene recurrence score assay impacts adjuvant therapy recommendations for er-positive, nodenegative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
by Eiermann, W and Rezai, M and Kümmel, S and Kühn, T and Warm, M and Friedrichs, K and Schneeweiss, A and Markmann, S and Eggemann, H and Hilfrich, J and Jackisch, C and Witzel, I and Eidtmann, H and Bachinger, A and Hell, S and Blohmer, J
Annals of Oncology, ISSN 0923-7534, 03/2013, Volume 24, Issue 3, pp. 618 - 624
Chemotherapy | Adjuvant | Breast cancer | Node negative | Node positive | Recurrence score
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) Who receive neoadjuvant chemotherapy: Results from ACO SOG Z107 1 (Alliance)
by Boughey, Judy C and Ballman, Karla V and Le-Petross, Huong T and McCall, Linda M and Mittendorf, Elizabeth A and Ahrendt, Gretchen M and Wilke, Lee G and Taback, Bret and Feliberti, Eric C and Hunt, Kelly K
Annals of Surgery, ISSN 0003-4932, 2016, Volume 263, Issue 4, pp. 802 - 807
Neoadjuvant chemotherapy | Axillary ultrasound | Node-positive breast cancer | Sentinel lymph node | Clipped node
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model
by Al-Alao, Osama and Mueller-Leonhard, Catrina and Kim, Simon P and Amin, Ali and Tucci, Christopher and Kott, Ohad and Mega, Anthony and Golijanin, Dragan and Gershman, Boris
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 10/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
by Eggermont, Alexander M.M and Chiarion-Sileni, Vanna and Grob, Jean-Jacques and Dummer, Reinhard and Wolchok, Jedd D and Schmidt, Henrik and Hamid, Omid and Robert, Caroline and Ascierto, Paolo A and Richards, Jon M and Lebbé, Céleste and Ferraresi, Virginia and Smylie, Michael and Weber, Jeffrey S and Maio, Michele and Bastholt, Lars and Mortier, Laurent and Thomas, Luc and Tahir, Saad and Hauschild, Axel and Hassel, Jessica C and Hodi, F. Stephen and Taitt, Corina and de Pril, Veerle and de Schaetzen, Gaetan and Suciu, Stefan and Testori, Alessandro
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1845 - 1855
Patients with surgically resected stage III melanoma are at high risk for recurrence. The 5-year survival rate with ipulimumab was 11 percentage points higher... 
HIGH-RISK MELANOMA | TRIAL | METASTATIC MELANOMA | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA | MULTICENTER | METAANALYSIS | ULCERATION | TUMOR BURDEN | CUTANEOUS MELANOMA | NODE-POSITIVE MELANOMA | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Adjuvants, Immunologic - adverse effects | Young Adult | Skin Neoplasms - mortality | Melanoma - drug therapy | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Melanoma - surgery | Neoplasm Staging | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Gastrointestinal Diseases - chemically induced | Gastrointestinal Diseases - immunology | Melanoma - mortality | Complications and side effects | Usage | Analysis | Melanoma | Adjuvant treatment | Clinical trials | Research | Cancer | Chemotherapy | Immune checkpoint | Risk groups | Body weight | Death | Survival | Drug dosages | Clinical outcomes | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
by Eggermont, Alexander M M, Prof and Chiarion-Sileni, Vanna, MD and Grob, Jean-Jacques, Prof and Dummer, Reinhard, Prof and Wolchok, Jedd D, MD and Schmidt, Henrik, MD and Hamid, Omid, MD and Robert, Caroline, Prof and Ascierto, Paolo A, Prof and Richards, Jon M, MD and Lebbé, Céleste, Prof and Ferraresi, Virginia, MD and Smylie, Michael, MD and Weber, Jeffrey S, MD and Maio, Michele, MD and Konto, Cyril, MD and Hoos, Axel, MD and de Pril, Veerle, MSc and Gurunath, Ravichandra Karra, MD and de Schaetzen, Gaetan, PhD and Suciu, Stefan, PhD and Testori, Alessandro, MD
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 522 - 530
Summary Background Ipilimumab is an approved treatment for patients with advanced melanoma. We aimed to assess ipilimumab as adjuvant therapy for patients with... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | MULTICENTER | THERAPY | METAANALYSIS | ULCERATION | ONCOLOGY | TUMOR BURDEN | CUTANEOUS MELANOMA | FOLLOW-UP | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | Adjuvants, Immunologic - administration & dosage | Double-Blind Method | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Combined Modality Therapy | Lymphatic Metastasis | Melanoma - pathology | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Adult | Female | Aged | Melanoma - surgery | Clinical trials | Surgery | Melanoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
by Eggermont, Alexander M.M and Blank, Christian U and Mandala, Mario and Long, Georgina V and Atkinson, Victoria and Dalle, Stéphane and Haydon, Andrew and Lichinitser, Mikhail and Khattak, Adnan and Carlino, Matteo S and Sandhu, Shahneen and Larkin, James and Puig, Susana and Ascierto, Paolo A and Rutkowski, Piotr and Schadendorf, Dirk and Koornstra, Rutger and Hernandez-Aya, Leonel and Maio, Michele and van den Eertwegh, Alfonsus J.M and Grob, Jean-Jacques and Gutzmer, Ralf and Jamal, Rahima and Lorigan, Paul and Ibrahim, Nageatte and Marreaud, Sandrine and van Akkooi, Alexander C.J and Suciu, Stefan and Robert, Caroline
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance
by Franceschini, Gianluca
European Journal of Surgical Oncology, ISSN 0748-7983, 10/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists
by Simons, J M and Maaskant-Braat, A J G and Luiten, E J T and Leidenius, M H K and van Nijnatten, T J A and Boelens, P G and Koppert, L B and van der Pol, C C and van de Velde, C J H and Audisio, R A and Smidt, M L
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, ISSN 0748-7983, 08/2019
Various options for axillary staging after neoadjuvant systemic therapy (NST) are available for breast cancer patients with a clinically positive axillary node... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Prospective Evaluation of the Impact of the 21‐Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node‐Positive Breast Cancer in Ontario, Canada
by Torres, Sofia and Trudeau, Maureen and Gandhi, Sonal and Warner, Ellen and Verma, Sunil and Pritchard, Kathleen I and Petrella, Teresa and Hew‐Shue, Mark and Chao, Calvin and Eisen, Andrea
The Oncologist, ISSN 1083-7159, 07/2018, Volume 23, Issue 7, pp. 768 - 775
Background The 21‐gene Recurrence Score (RS) assay is only reimbursed in Ontario for node‐negative and micrometastatic node‐positive (N+) early‐stage breast... 
Adjuvant chemotherapy | Breast cancer | Node positive | Recurrence score | TREATMENT RECOMMENDATIONS | TAMOXIFEN | RISK | SYSTEMIC THERAPY | REGIMENS | CHEMOTHERAPY | ONCOLOGY | EXPRESSION | AMERICAN SOCIETY | Breast Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
by Simons, Janine M and van Nijnatten, Thiemo J A and van der Pol, Carmen C and Luiten, Ernest J T and Koppert, Linetta B and Smidt, Marjolein L
Annals of Surgery, ISSN 0003-4932, 03/2019, Volume 269, Issue 3, pp. 432 - 442
OBJECTIVE:The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging procedures... 
Neoadjuvant therapy | Usage | Care and treatment | Breast cancer | Diagnosis | Meta-analysis | Meta-Analysis | sentinel lymph node biopsy | iodine seed | breast cancer | node-positive | neoadjuvant systemic therapy | axillary staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer
by Mehanna, Hisham and Wong, Wai-Lup and McConkey, Christopher C and Rahman, Joy K and Robinson, Martin and Robinson, Max and Hartley, Andrew G.J and Nutting, Christopher and Powell, Ned and Al-Booz, Hoda and Junor, Elizabeth and Rizwanullah, Mohammed and V. von Zeidler, Sandra and Wieshmann, Hulya and Hulme, Claire and Smith, Alison F and Hall, Peter and Dunn, Janet and PET-NECK Trial Management Grp and PET-NECK Trial Management Group
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 15, pp. 1444 - 1454
Among patients who received chemotherapy for advanced head and neck cancer, 2-year overall survival was 81.5% in the group assigned to immediate radical neck... 
NODE-POSITIVE HEAD | MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | MANAGEMENT | SQUAMOUS-CELL CARCINOMA | CHEMORADIOTHERAPY | RISK | RADIOTHERAPY | COMPUTED-TOMOGRAPHY | EORTC QLQ-C30 | Lymphatic Metastasis - diagnosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - surgery | Male | Survival Rate | Tomography, X-Ray Computed | Positron-Emission Tomography | Chemoradiotherapy | Carcinoma, Squamous Cell - diagnosis | Intention to Treat Analysis | Quality of Life | Female | Head and Neck Neoplasms - diagnosis | Neoplasm Staging | Head and Neck Neoplasms - surgery | Neck Dissection | Care and treatment | Usage | Chemotherapy | PET imaging | Head and neck cancer | Diagnosis | Medical care, Cost of | Cancer | p16 Protein | Clinical trials | Cancer therapies | Patients | Quality of life | Computed tomography | Oropharyngeal cancer | Surgery | Tomography | Neck | Head & neck cancer | Positron emission tomography | Dissection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy
by Bravi, Carlo Andrea and Tin, Amy and Vertosick, Emily and Mazzone, Elio and Bandini, Marco and Dell'Oglio, Paolo and Stabile, Armando and Gandaglia, Giorgio and Fossati, Nicola and Sjoberg, Daniel and Touijer, Karim and Cozzarini, Cesare and Briganti, Alberto and Montorsi, Francesco and Eastham, James and Vickers, Andrew
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 10/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection
by Abdollah, Firas and Dalela, Deepansh and Sood, Akshay and Keeley, Jacob and Alanee, Shaheen and Briganti, Alberto and Montorsi, Francesco and Peabody, James O and Menon, Mani
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 253 - 256
Using institutional data, we have previously developed an algorithm to identify the optimal candidates for adjuvant radiotherapy (aRT) among men with pN1... 
Adjuvant radiotherapy | Lymph node dissection | Radical prostatectomy | Prostate cancer | Node-positive disease | Lymph node invasion | SURVIVAL | UROLOGY & NEPHROLOGY | IMMEDIATE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery
by Allweis, Tanir M and Menes, Tehillah and Rotbart, Noa and Rapson, Yael and Cernik, Hana and Bokov, Inna and Diment, Judith and Magen, Ada and Golan, Orit and Levi-Bendet, Noa and Givon Madhala, Osnat and Grubstein, Ahuva
European Journal of Surgical Oncology, ISSN 0748-7983, 11/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommnendation to optimize the performance
by Simons, J.M and Maaskant-Braat, A.J.G and Luiten, E.J.T and Leidenius, M.H and van Nijnatten, T.J.A and Boelens, P.G and Koppert, L.B and van der Pol, C.C and van de Velde, C.J.H and Audisio, R.A and Smidt, M.L
European Journal of Surgical Oncology, ISSN 0748-7983, 10/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)
by Boughey, Judy C and Ballman, Karla V and Le-Petross, Huong T and McCall, Linda M and Mittendorf, Elizabeth A and Ahrendt, Gretchen M and Wilke, Lee G and Taback, Bret and Feliberti, Eric C and Hunt, Kelly K
Annals of Surgery, ISSN 0003-4932, 04/2016, Volume 263, Issue 4, pp. 802 - 807
BACKGROUND:The American College of Surgeons Oncology Group Z1071 trial reported a false-negative rate (FNR) of 12.6% with sentinel lymph node (SLN) surgery... 
SURGERY | clipped node | neoadjuvant chemotherapy | node-positive breast cancer | FINE-NEEDLE-ASPIRATION | ULTRASOUND | METASTASES | BIOPSY | axillary ultrasound | sentinel lymph node | CYTOLOGY | Lymph Node Excision | Breast Neoplasms - surgery | Carcinoma, Lobular - pathology | Fiducial Markers | Lymph Nodes - pathology | Prospective Studies | Lymph Nodes - surgery | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Agents - therapeutic use | Carcinoma, Ductal, Breast - drug therapy | Axilla | Adult | Carcinoma, Ductal, Breast - pathology | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | False Negative Reactions | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Breast Neoplasms - pathology | Aged | Carcinoma, Lobular - drug therapy | Sentinel Lymph Node Biopsy | Neoplasm Staging | Z1071
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer
by Chapman, Bhavana V and Swanick, Cameron W and Ning, Matthew S and Allen, Pamela K and Soliman, Pamela T and Westin, Shannon N and Pardeshi, Vishakha and Broaddus, Russell R and Lu, Karen H and Jhingran, Anuja and Eifel, Patricia J and Klopp, Ann H
Gynecologic Oncology, ISSN 0090-8258, 07/2019, Volume 154, Issue 1, pp. 22 - 28
To identify the optimal adjuvant treatment regimen for patients with endometrioid and non-endometrioid node-positive endometrial cancer. We retrospectively... 
Endometrioid | FIGO stage IIIC endometrial cancer | Node-positive endometrial cancer | Non-endometrioid | Adjuvant therapy | Care and treatment | Endometrial cancer | Adjuvant treatment | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer
by Simons, J.M and van Nijnatten, TJA and van der Pol, C.C and Luiten, E.J.T and Koppert, Linetta and Smidt, M.L
Annals of Surgery, ISSN 0003-4932, 01/2019, Volume 269, Issue 3, pp. 432 - 442
textabstractObjective: The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging... 
breast cancer | node-positive | sentinel lymph node biopsy | iodine seed | neoadjuvant systemic therapy | axillary staging | SURGERY | MULTICENTER | FEASIBILITY | MARKING | LYMPH-NODES | BIOPSY | RADIOACTIVE IODINE SEEDS | WIRE LOCALIZATION | PREOPERATIVE CHEMOTHERAPY | CLIPPED NODE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study
by Mook, Stella and Schmidt, Marjanka K and Viale, Giuseppe and Pruneri, Giancarlo and Eekhout, Inge and Floore, Arno and Glas, Annuska M and Bogaerts, Jan and Cardoso, Fatima and Piccart-Gebhart, Martine J and Rutgers, Emiel T and Van't Veer, Laura J and TRANSBIG Consortium and On behalf of the TRANSBIG consortium
Breast Cancer Research and Treatment, ISSN 0167-6806, 07/2009, Volume 116, Issue 2, pp. 295 - 302
Purpose The 70-gene prognosis-signature has shown to be a valid prognostic tool in node-negative breast cancer. Although axillary lymph node status is... 
Node-positive breast cancer | Gene expression signature | Prognosis | SURVIVAL | GENE-EXPRESSION SIGNATURE | WOMEN | ONCOLOGY | ADJUVANT | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Gene Expression Profiling | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Lymphatic Metastasis - pathology | Adult | Breast Neoplasms - mortality | Female | Neoplasm Recurrence, Local - genetics | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer
by Bogani, Giorgio and Vinti, Daniele and Murgia, Ferdinando and Chiappa, Valentina and Leone Roberti Maggiore, Umberto and Martinelli, Fabio and Ditto, Antonino and Raspagliesi, Francesco
International Journal of Gynecologic Cancer, ISSN 1048-891X, 11/2019, Volume 29, Issue 9, pp. 1355 - 1360
ObjectiveNodal involvement is one of the most important prognostic factors in cervical cancer patients. We aimed to assess the prognostic role in relation to... 
MANAGEMENT | radiation and chemotherapy | RANDOMIZED-TRIAL | cervical cancer | IFOSFAMIDE | stage IIIC | PACLITAXEL | OBSTETRICS & GYNECOLOGY | node positive | RADICAL SURGERY | CISPLATIN | ONCOLOGY | CARCINOMA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights